Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency

AG Dunn, E Coiera, KD Mandl… - Research integrity and …, 2016 - Springer
Conflicts of interest held by researchers remain a focus of attention in clinical research.
Biases related to these relationships have the potential to directly impact the quality of …

Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts

JS Yeh, JM Franklin, J Avorn, J Landon… - JAMA internal …, 2016 - jamanetwork.com
Importance Pharmaceutical industry payments to physicians may affect prescribing practices
and increase costs if more expensive medications are prescribed. Objective Determine the …

A 9-year investigation of healthcare industry payments to pulmonologists in the United States

A Murayama, H Kugo, Y Saito, H Saito… - Annals of the …, 2023 - atsjournals.org
Rationale: The healthcare industry sometimes makes payments to physicians for
nonresearch and research purposes in the United States. Objectives: We aimed to evaluate …

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database …

A Murayama, K Nakano, S Kamamoto, M Sato… - Clinical Microbiology …, 2022 - Elsevier
Objective To evaluate the trend in nonresearch payments made by the industries to the
infectious disease physicians in the United States since the launch of the Open Payments …

Financial relationships between pharmaceutical companies and rheumatologists in Japan between 2016 and 2019

A Murayama, H Mamada, H Shigeta… - JCR: Journal of …, 2023 - journals.lww.com
Methods Using payment data publicly disclosed by 92 major pharmaceutical companies, we
evaluated the financial relationships between pharmaceutical companies and …

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019

A Murayama, S Kamamoto, M Kawashima, H Saito… - BMJ open, 2023 - bmjopen.bmj.com
Objectives Limited evidence is available regarding the financial relationships between
gastroenterologists and pharmaceutical companies in Japan. This study analysed the …

The effect of information disclosure on industry payments to physicians

T Guo, S Sriram, P Manchanda - Journal of Marketing …, 2021 - journals.sagepub.com
In 2019, US pharmaceutical companies paid 3.6billiontophysiciansintheformofgiftstopromot…
.Tocurbinappropriatefinancialrelationshipsb…,severalstatelawsrequirefirmstopubliclydecla …

Making medicines affordable: a national imperative

SJ Nass, G Madhavan, NR Augustine - 2018 - books.google.com
Thanks to remarkable advances in modern health care attributable to science, engineering,
and medicine, it is now possible to cure or manage illnesses that were long deemed …

Industry‐sponsored meal payments are associated with prescriptions and Medicare expenditures on brand‐name colchicine in the United States

A Murayama - International Journal of Rheumatic Diseases, 2024 - Wiley Online Library
Aim To investigate the association between industry‐sponsored meal payments and the
prescribing patterns of brand‐name colchicines, namely Colcrys and Mitigare, among …

A nine-year investigation of industry research and nonresearch payments to emergency physicians in the United States between 2014 and 2022

A Murayama - The Journal of Emergency Medicine, 2024 - Elsevier
Background Financial relationships between physicians and the health care industry are
common in the United States. Yet, there are limited data on payments to emergency …